A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen

Quang Toan Pham, Maxime Veillette, Alberto Brandariz-Nuñez, Paulina Pawlica, Caroline Thibert-Lefebvre, Nadia Chandonnet, Felipe Diaz-Griffero, Lionel Berthoux

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Human-derived antiretroviral transgenes are of great biomedical interest and are actively pursued. HIV-1 is efficiently inhibited at post-entry, pre-integration replication stages by point mutations in the variable region 1 (v1) of the human restriction factor TRIM5α. Here we use a mutated megaprimer approach to create a mutant library of TRIM5αHu v1 and to isolate a mutation at Gly330 (G330E) that inhibits transduction of an HIV-1 vector as efficiently as the previously described mutants at positions Arg332 and Arg335. As was the case for these other mutations, modification of the local v1 charge toward increased acidity was key to inhibiting HIV-1. G330E TRIM5αHu also disrupted replication-competent HIV-1 propagation in a human T cell line. Interestingly, G330E did not enhance restriction of HIV-1 when combined with mutations at Arg332 or Arg335. Accordingly, the triple mutant G330E-R332G-R335G bound purified recombinant HIV-1 capsid tubes less efficiently than the double mutant R332G-R335G did. In a structural model of the TRIM5αHu PRYSPRY domain, the addition of G330E to the double mutant R332G-R335G caused extensive changes to the capsid-binding surface, which may explain why the triple mutant was no more restrictive than the double mutant. The HIV-1 inhibitory potential of Gly330 mutants was not predicted by examination of natural TRIM5α orthologs that are known to strongly inhibit HIV-1. This work underlines the potential of random mutagenesis to isolate novel variants of human proteins with antiviral properties.

Original languageEnglish (US)
Pages (from-to)306-314
Number of pages9
JournalVirus Research
Volume173
Issue number2
DOIs
StatePublished - May 2013

Fingerprint

HIV-1
Capsid
Mutation
Structural Models
Transgenes
Point Mutation
Mutagenesis
Antiviral Agents
T-Lymphocytes
Cell Line
Proteins

Keywords

  • Genetic screen
  • HIV-1
  • Random mutagenesis
  • Restriction
  • TRIM5α

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases
  • Cancer Research

Cite this

Pham, Q. T., Veillette, M., Brandariz-Nuñez, A., Pawlica, P., Thibert-Lefebvre, C., Chandonnet, N., ... Berthoux, L. (2013). A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen. Virus Research, 173(2), 306-314. https://doi.org/10.1016/j.virusres.2013.01.013

A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen. / Pham, Quang Toan; Veillette, Maxime; Brandariz-Nuñez, Alberto; Pawlica, Paulina; Thibert-Lefebvre, Caroline; Chandonnet, Nadia; Diaz-Griffero, Felipe; Berthoux, Lionel.

In: Virus Research, Vol. 173, No. 2, 05.2013, p. 306-314.

Research output: Contribution to journalArticle

Pham, QT, Veillette, M, Brandariz-Nuñez, A, Pawlica, P, Thibert-Lefebvre, C, Chandonnet, N, Diaz-Griffero, F & Berthoux, L 2013, 'A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen', Virus Research, vol. 173, no. 2, pp. 306-314. https://doi.org/10.1016/j.virusres.2013.01.013
Pham QT, Veillette M, Brandariz-Nuñez A, Pawlica P, Thibert-Lefebvre C, Chandonnet N et al. A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen. Virus Research. 2013 May;173(2):306-314. https://doi.org/10.1016/j.virusres.2013.01.013
Pham, Quang Toan ; Veillette, Maxime ; Brandariz-Nuñez, Alberto ; Pawlica, Paulina ; Thibert-Lefebvre, Caroline ; Chandonnet, Nadia ; Diaz-Griffero, Felipe ; Berthoux, Lionel. / A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen. In: Virus Research. 2013 ; Vol. 173, No. 2. pp. 306-314.
@article{beb8c04b35cb405cb8da86201ae251d3,
title = "A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen",
abstract = "Human-derived antiretroviral transgenes are of great biomedical interest and are actively pursued. HIV-1 is efficiently inhibited at post-entry, pre-integration replication stages by point mutations in the variable region 1 (v1) of the human restriction factor TRIM5α. Here we use a mutated megaprimer approach to create a mutant library of TRIM5αHu v1 and to isolate a mutation at Gly330 (G330E) that inhibits transduction of an HIV-1 vector as efficiently as the previously described mutants at positions Arg332 and Arg335. As was the case for these other mutations, modification of the local v1 charge toward increased acidity was key to inhibiting HIV-1. G330E TRIM5αHu also disrupted replication-competent HIV-1 propagation in a human T cell line. Interestingly, G330E did not enhance restriction of HIV-1 when combined with mutations at Arg332 or Arg335. Accordingly, the triple mutant G330E-R332G-R335G bound purified recombinant HIV-1 capsid tubes less efficiently than the double mutant R332G-R335G did. In a structural model of the TRIM5αHu PRYSPRY domain, the addition of G330E to the double mutant R332G-R335G caused extensive changes to the capsid-binding surface, which may explain why the triple mutant was no more restrictive than the double mutant. The HIV-1 inhibitory potential of Gly330 mutants was not predicted by examination of natural TRIM5α orthologs that are known to strongly inhibit HIV-1. This work underlines the potential of random mutagenesis to isolate novel variants of human proteins with antiviral properties.",
keywords = "Genetic screen, HIV-1, Random mutagenesis, Restriction, TRIM5α",
author = "Pham, {Quang Toan} and Maxime Veillette and Alberto Brandariz-Nu{\~n}ez and Paulina Pawlica and Caroline Thibert-Lefebvre and Nadia Chandonnet and Felipe Diaz-Griffero and Lionel Berthoux",
year = "2013",
month = "5",
doi = "10.1016/j.virusres.2013.01.013",
language = "English (US)",
volume = "173",
pages = "306--314",
journal = "Virus Research",
issn = "0168-1702",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen

AU - Pham, Quang Toan

AU - Veillette, Maxime

AU - Brandariz-Nuñez, Alberto

AU - Pawlica, Paulina

AU - Thibert-Lefebvre, Caroline

AU - Chandonnet, Nadia

AU - Diaz-Griffero, Felipe

AU - Berthoux, Lionel

PY - 2013/5

Y1 - 2013/5

N2 - Human-derived antiretroviral transgenes are of great biomedical interest and are actively pursued. HIV-1 is efficiently inhibited at post-entry, pre-integration replication stages by point mutations in the variable region 1 (v1) of the human restriction factor TRIM5α. Here we use a mutated megaprimer approach to create a mutant library of TRIM5αHu v1 and to isolate a mutation at Gly330 (G330E) that inhibits transduction of an HIV-1 vector as efficiently as the previously described mutants at positions Arg332 and Arg335. As was the case for these other mutations, modification of the local v1 charge toward increased acidity was key to inhibiting HIV-1. G330E TRIM5αHu also disrupted replication-competent HIV-1 propagation in a human T cell line. Interestingly, G330E did not enhance restriction of HIV-1 when combined with mutations at Arg332 or Arg335. Accordingly, the triple mutant G330E-R332G-R335G bound purified recombinant HIV-1 capsid tubes less efficiently than the double mutant R332G-R335G did. In a structural model of the TRIM5αHu PRYSPRY domain, the addition of G330E to the double mutant R332G-R335G caused extensive changes to the capsid-binding surface, which may explain why the triple mutant was no more restrictive than the double mutant. The HIV-1 inhibitory potential of Gly330 mutants was not predicted by examination of natural TRIM5α orthologs that are known to strongly inhibit HIV-1. This work underlines the potential of random mutagenesis to isolate novel variants of human proteins with antiviral properties.

AB - Human-derived antiretroviral transgenes are of great biomedical interest and are actively pursued. HIV-1 is efficiently inhibited at post-entry, pre-integration replication stages by point mutations in the variable region 1 (v1) of the human restriction factor TRIM5α. Here we use a mutated megaprimer approach to create a mutant library of TRIM5αHu v1 and to isolate a mutation at Gly330 (G330E) that inhibits transduction of an HIV-1 vector as efficiently as the previously described mutants at positions Arg332 and Arg335. As was the case for these other mutations, modification of the local v1 charge toward increased acidity was key to inhibiting HIV-1. G330E TRIM5αHu also disrupted replication-competent HIV-1 propagation in a human T cell line. Interestingly, G330E did not enhance restriction of HIV-1 when combined with mutations at Arg332 or Arg335. Accordingly, the triple mutant G330E-R332G-R335G bound purified recombinant HIV-1 capsid tubes less efficiently than the double mutant R332G-R335G did. In a structural model of the TRIM5αHu PRYSPRY domain, the addition of G330E to the double mutant R332G-R335G caused extensive changes to the capsid-binding surface, which may explain why the triple mutant was no more restrictive than the double mutant. The HIV-1 inhibitory potential of Gly330 mutants was not predicted by examination of natural TRIM5α orthologs that are known to strongly inhibit HIV-1. This work underlines the potential of random mutagenesis to isolate novel variants of human proteins with antiviral properties.

KW - Genetic screen

KW - HIV-1

KW - Random mutagenesis

KW - Restriction

KW - TRIM5α

UR - http://www.scopus.com/inward/record.url?scp=84876858334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876858334&partnerID=8YFLogxK

U2 - 10.1016/j.virusres.2013.01.013

DO - 10.1016/j.virusres.2013.01.013

M3 - Article

VL - 173

SP - 306

EP - 314

JO - Virus Research

JF - Virus Research

SN - 0168-1702

IS - 2

ER -